Compugen Stock

Compugen FCF/Net Income

The Free Cash Flow to Net Income Ratio of Compugen (CGEN) as of Aug 12, 2026 is 88.64 %. In the previous year, Free Cash Flow to Net Income Ratio was -347.73 % — a change of -125.49% (higher).

FCF/Net Income

88.64 %

YoY

-125.49%

Last updated:

Free Cash Flow to Net Income Ratio of Compugen is 2026 88.64 % . Free Cash Flow to Net Income Ratio of Compugen was 2025 -347.73 % . It decreases by -125.49% higher compared to the previous year.
Access this data via the Eulerpool API

Compugen Stock analysis

What does Compugen do? Compugen Ltd is an Israeli biotechnology company focused on the development of therapeutics and diagnostic products. It was founded in 1993 and is headquartered in Tel Aviv. Compugen is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Compugen stock

Free Cash Flow to Net Income Ratio of Compugen is 88.64 % in 2026.

Free Cash Flow to Net Income Ratio of Compugen changed from -347.73 % to 88.64 %, representing a -125.49% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Free Cash Flow to Net Income Ratio Compugen since 2006 – with annual values, charts, and detailed analysis.

The FCF/Net Income ratio measures cash flow quality. Ratios consistently above 100% suggest high-quality earnings with strong cash backing.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Free Cash Flow to Net Income Ratio's Compugen with sector peers and the industry average to assess whether it is attractive.

To evaluate Free Cash Flow to Net Income Ratio's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Free Cash Flow to Net Income Ratio.

Access this data via the Eulerpool API

Cash Flow — Compugen

All Key Metrics — Compugen